1. Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line

   • Philip G. Cavanaugh
   • Li Bin Jia
   • Garth L. Nicolson

   OriginalPaper Pages: 201 - 215

2. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence–based amplification for the detection of circulating breast cancer cells

   • A.C. Lambrechts
   • A.J. Bosma
   • S. Rodenhuis

   OriginalPaper Pages: 217 - 229

3. Weekly epirubicin plus lonidamine in advanced breast carcinoma

   • Cecilia Nisticò
   • Carlo Garufi
   • Edmondo Terzoli

   OriginalPaper Pages: 231 - 235

4. Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group

   • Giuseppe Frasci
   • Giuseppe D'Aiuto
   • Giuseppe Comella

   OriginalPaper Pages: 237 - 250

5. pS2 (TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers

   • Bradley E. Gillesby
   • Timothy R. Zacharewski

   OriginalPaper Pages: 251 - 263

6. Effective treatment of advanced estrogen–independent MXT mouse mammary cancers with targeted cytotoxic LH–RH analogs

   • Karoly Szepeshazi
   • Andrew V. Schally
   • Attila Nagy

   OriginalPaper Pages: 265 - 274

7. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR–dependent gene expression

   • L. Yang
   • D. Munoz–Medellin
   • P.H. Brown

   OriginalPaper Pages: 275 - 289